A groundbreaking study conducted by researchers from McGill University, the Lady Davis Institute for Medical Research (LDI) ...

A new study has identified a potential new target for treating triple-negative breast cancer, one of the most aggressive ...

Frailty is associated with higher odds of local and systemic postoperative complications among older women with nonmetastatic ...

Thousands of survivors, health care professionals, and community organizers are rallying this Breast Cancer Awareness season ...

New results from a clinical trial show that existing drugs can successfully kill dormant breast cancer cells, thereby reducing lifetime risk of recurrence.

As technology improves, Columbus-area doctors say more patients are undergoing testing to see if they have an elevated risk ...

A study published in the Journal of Geriatric Oncology highlights a significant gap in the care of older adults with breast ...

The administration’s fiscal year 2026 proposed budget included devastating cuts to the National Institutes of Health (NIH) ...

Metastasis, the primary cause of cancer-related mortality, is driven by alterations in the tumor microenvironment (TME). Triple-negative breast cancer (TNBC), characterized by the lack of estrogen ...

A first-of-its-kind clinical trial identified risk of breast cancer recurrence and successfully treated dormant tumor cells using existing drugs.

Breast cancer is the most common cancer in women worldwide. In sub-Saharan Africa, it is a leading cause of cancer-related ...